SightfileU.S. market data from official filings

ARTIVION INC (AORT)

Name: ARTIVION INC (AORT) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000784199 · EDGAR filings · Updated 2026-06-15

ARTIVION INC (AORT) has reported institutional ownership of 91.5%, with 238 institutional managers holding positions valued at $1.63B per the latest 13F reporting period.

Institutional ownership

91.5%

Institutional managers

238

Reported 13F value

$1.63B

Insider activity

115 trans.

−$23.0M net selling

Latest updates

2026-06-15 — Insider transaction reported (Form 4)
2026-06-11 — Notice of proposed sale filed (Form 144)
2026-06-08 — Initial insider ownership filed (Form 3)
2026-06-04 — Insider transaction reported (Form 4)
2026-05-21 — SD filed
2026-05-20 — 4/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ARTIVION INC has 238 institutional holders and institutional ownership of 91.5%.

Insider activity

Insiders reported 115 transactions (0 buys, 74 sells) across 14 reporting insiders, with a net reported value of −$23.0M.

Related companies

NATIONAL HEALTHCARE CORP (NHC) · RAPPORT THERAPEUTICS INC (RAPP) · VERADERMICS INC (MANE) · TREVI THERAPEUTICS INC (TRVI) · HEARTFLOW INC (HTFL) · AMYLYX PHARMACEUTICALS INC (AMLX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.